

2 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Rogue Venture Partners Fund VFiled to raise in 2026, with no closing reported yet. | 2026 | $15M | $0 | 0 |
| Rogue Women's Fund II | August 2022 | $13M | $13M | 31 |
| Rogue I | 2021 | Indefinite | $150M | 1 |
| ROGUE VENTURE PARTNERS FUND III | February 2018 | $30M | $5.3M | 28 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
14 partners are named across this firm’s filings, 2 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Paul MeisterNot on the current fund | Active | Biotech & pharma, Medical devices, Digital health | 17 | 4 |
| Richard MillerNot on the current fund | Selective | Biotech & pharma, Digital health, Climate & energy | 27 | 3 |
| Eric LevinNot on the current fund | Slowing | Digital health, Media & creator tools | 2 | 1 |
| Adam Stoll | Quiet | Medical devices | 2 | 0 |
| Burke MontgomeryNot on the current fund | Quiet | None listed | 0 | 0 |
| Caroline Lewis Palmer | Quiet | None listed | 0 | 0 |
| Francis IdehenNot on the current fund | Quiet | None listed | 0 | 0 |
| Frederick PollockNot on the current fund | Quiet | None listed | 0 | 0 |
| John StirekNot on the current fund | Quiet | None listed | 0 | 0 |
| Jonathan LevinNot on the current fund | Quiet | Data & analytics | 1 | 0 |
| Michael SacksNot on the current fund | Quiet | Media & creator tools | 1 | 0 |
| Pamela BentleyNot on the current fund | Quiet | None listed | 0 | 0 |
| Sandra HurseNot on the current fund | Quiet | None listed | 0 | 0 |
| Stacie SelingerNot on the current fund | Quiet | None listed | 0 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Categories of Rogue’s own portfolio companies, based on 37 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Rogue’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Novalis Lifesciences Investments | 16 | ACTIV Surgical, Arbor Biotechnologies, BlueWhale Bio, Everest Biolabs, Flywheel Exchange, INVENTIV HEALTH, Kumanu, LevitasBio, LumaCyte, Magnolia Medical Technologies, Mercy BioAnalytics, Perfect Air Holdco, Quanterix, Telesis Bio, vTv Therapeutics, Way Biosolutions |
| ARCH Venture Partners | 2 | Arbor Biotechnologies, Quanterix |
| Sofinnova Venture Partners | 2 | Bolt Biotherapeutics, Magnolia Medical Technologies |
| Vivo Capital | 2 | Arbor Biotechnologies, Bolt Biotherapeutics |
| Accel | 1 | Chainalysis |
| Addition | 1 | Chainalysis |
| Aditum Bio | 1 | vTv Therapeutics |
| Bain Capital Ventures | 1 | Quanterix |
| Benchmark | 1 | Chainalysis |
| Blueprint N1 | 1 | Kumanu |
| Broadoak | 1 | Telesis Bio |
| Canapi Ventures SBIC | 1 | INRANGE SYSTEMS |
| Cota Capital | 1 | ACTIV Surgical |
| Greatpoint Ventures Innovation | 1 | ACTIV Surgical |
| Healthquest Partners | 1 | Magnolia Medical Technologies |
A shared board seat: a company where filings name a Rogue partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.